Miridesap

DB13087InvestigationalSmall molecule

Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

Mechanism: Pharmacologically active on Serum amyloid P-component
Curator reviewed
Formula / weight: C₁₆H₂₄N₂O₆ · 340.376 g/mol (avg)
Also known as: CPHPC
Code names: RO-638695

Resolves to

Compound

Structure

InChIKeyHZLAWYIBLZNRFZ-VXGBXAGGSA-NSMILESOC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(O)=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Miridesap, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.